Search research articles
Contact Us
Filters
Showing results (511-520 of 585) with videos related to
Page
of 59
Sort By:
Journal of Inherited Metabolic Disease
|
April 11, 2015
Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria
Jean-Baptiste Arnoux, Kim-Hanh Le Quan Sang, Anais Brassier, et al.
Human Molecular Genetics
|
May 25, 2026
Specific knockout of kidney homogentisate 1,2-dioxygenase reveals that local metabolism of tyrosine and homogentisic acid is negligible in alkaptonuria
Dominic A Rutland, Brendan P Norman, Juliette H Hughes, et al.
Metabolites
|
August 25, 2022
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Mayo Clinic Proceedings
|
May 17, 2025
Polypharmacy and Potentially Inappropriate Medications in Adults ≥75 Years of Age by Dementia and Frailty Status: The ARIC Study
Pamela L Lutsey, Jeffrey R Misialek, Eric A Whitsel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 9, 2025
Assessment of the Modified Rankin Scale in Electronic Health Records with a Fine-tuned Large Language Model
Luis Silva, Marcus Milani, Sohum Bindra, et al.
Metabolites
|
October 27, 2022
Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria
Lakshminarayan R Ranganath, Andrew T Hughes, Andrew S Davison, et al.
Tobacco Prevention & Cessation
|
November 16, 2022
Prevalence and factors associated with tobacco use among beneficiaries attending the youth mental health promotion clinics (Yuvaspandana Kendra) in India: A case-record analysis
Gautham M Sukumar, Pradeep Banandur, Vaishali Dagar, et al.
Clinical Chemistry
|
February 21, 2019
A Comprehensive LC-QTOF-MS Metabolic Phenotyping Strategy: Application to Alkaptonuria
Brendan P Norman, Andrew S Davison, Gordon A Ross, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
December 16, 2017
Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease
Christine M Burns, David S Knopman, David E Tupper, et al.
Journal of Inherited Metabolic Disease
|
September 11, 2019
Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria
Juliette H Hughes, Peter J M Wilson, Hazel Sutherland, et al.
Page
of 59
Search research articles
Search
Showing results (511-520 of 585) with videos related to
Sort By:
Page
of 59
Journal of Inherited Metabolic Disease
|
April 11, 2015
Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria
Jean-Baptiste Arnoux, Kim-Hanh Le Quan Sang, Anais Brassier, et al.
Human Molecular Genetics
|
May 25, 2026
Specific knockout of kidney homogentisate 1,2-dioxygenase reveals that local metabolism of tyrosine and homogentisic acid is negligible in alkaptonuria
Dominic A Rutland, Brendan P Norman, Juliette H Hughes, et al.
Metabolites
|
August 25, 2022
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Mayo Clinic Proceedings
|
May 17, 2025
Polypharmacy and Potentially Inappropriate Medications in Adults ≥75 Years of Age by Dementia and Frailty Status: The ARIC Study
Pamela L Lutsey, Jeffrey R Misialek, Eric A Whitsel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 9, 2025
Assessment of the Modified Rankin Scale in Electronic Health Records with a Fine-tuned Large Language Model
Luis Silva, Marcus Milani, Sohum Bindra, et al.
Metabolites
|
October 27, 2022
Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria
Lakshminarayan R Ranganath, Andrew T Hughes, Andrew S Davison, et al.
Tobacco Prevention & Cessation
|
November 16, 2022
Prevalence and factors associated with tobacco use among beneficiaries attending the youth mental health promotion clinics (Yuvaspandana Kendra) in India: A case-record analysis
Gautham M Sukumar, Pradeep Banandur, Vaishali Dagar, et al.
Clinical Chemistry
|
February 21, 2019
A Comprehensive LC-QTOF-MS Metabolic Phenotyping Strategy: Application to Alkaptonuria
Brendan P Norman, Andrew S Davison, Gordon A Ross, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
December 16, 2017
Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease
Christine M Burns, David S Knopman, David E Tupper, et al.
Journal of Inherited Metabolic Disease
|
September 11, 2019
Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria
Juliette H Hughes, Peter J M Wilson, Hazel Sutherland, et al.
Page
of 59